ReviewJournal of clinical microbiology2020
Diagnostic Mycology: Xtreme Challenges.
Review in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 23 citations in OpenAlex.
- A Laboratory-Developed Assay for the Simultaneous Detection ofJournal of fungi (Basel, Switzerland) · 2025Article
- Advancing Dermatomycosis Diagnosis: Evaluating a Microarray-Based Platform for Rapid and Accurate Fungal Detection-A Pilot Study.Journal of fungi (Basel, Switzerland) · 2025Article
- A novel, rapid, ultrasensitive diagnosis platform for detectingFrontiers in cellular and infection microbiology · 2024Article
- Performance of the VITEK® MS system for the identification of filamentous fungi in a microbiological laboratory in Chile.PloS one · 2024Article
- Chip-Based Molecular Evaluation of a DNA Extraction Protocol forMicroorganisms · 2023Article
- Antibodies as Models and Tools to DecipherJournal of fungi (Basel, Switzerland) · 2023Review
- Fungal Whole-Genome Sequencing for Species Identification: From Test Development to Clinical Utilization.Journal of fungi (Basel, Switzerland) · 2023Article
- Cross-sectional investigation of mycological diagnosis challenges in Saudi Arabia.Frontiers in cellular and infection microbiology · 2023Article
- Whole-genome single nucleotide polymorphism analysis for typing the pandemic pathogenFrontiers in microbiology · 2022Article
- Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.Journal of fungi (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Developing any diagnostic assay that receives United States Food and Drug Administration (FDA) approval can be a slow and difficult process. FDA-approved assays for fungal diagnosis are generally few in number and are focused mainly on diagnosing candidiasis, which is caused by several species of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.